Management is prioritizing the Modern Oral segment, which grew 266% year-over-year, as the primary engine for long-term value creation.

The company is intentionally accepting 'opportunity costs' in the legacy Zig-Zag segment, which saw a 13% revenue decline, to focus resources on the pouch category.

A 'front-loaded' investment strategy is being employed to capture high lifetime value consumers who demonstrate consistent repeat purchasing patterns over decades.

Management believes the nicotine pouch market will consolidate into 5 to 6 dominant brands and is positioning FRE and ALP to capture double-digit market share.

Operational focus has shifted toward doubling the sales force and establishing domestic U.S. manufacturing to supplement international supply and eventually enhance margins.

The launch of 'Stoker’s Proud' serves as a strategic flanker brand to capture value-seeking consumers while protecting the core brand's pricing integrity.

Initiated 2026 Modern Oral net revenue guidance of $180 million to $190 million, supported by a significant increase in marketing spend.

Anticipate a major brick-and-mortar expansion for the ALP brand in Q2 2026, moving ahead of the original D2C-only schedule.

EBITDA guidance is currently limited to Q1 2026 ($24 million to $27 million) due to the 'lumpy' and opportunistic nature of planned marketing investments.

Domestic manufacturing lines are expected to be qualified within the next several months, with margin benefits likely appearing toward the end of 2026.

The company plans to spend $3 million to $5 million in 2026 specifically to supplement Modern Oral PMTA regulatory filings.

Fourth quarter gross margins were impacted by an elevated tariff rate on white pouch products, which was adjusted in EBITDA but remained a drag on reported gross margin.

Increased outbound freight charges and planned SG&A increases for sales headcount contributed to a $3.1 million sequential rise in operating expenses.

The company is utilizing a 'contra revenue' accounting treatment for certain white pouch investments, leading to a $40 million to $50 million spread between gross and net revenue guidance.

Our analysts just identified a stock with the potential to be the next Nvidia. Tell us how you invest and we'll show you why it's our #1 pick. Tap here.

U.S. production will supplement rather than replace the existing Indian partnership to ensure no supply chain constraints during rapid growth.

Margin enhancements from domestic production will take time to flow through the P&L, with 'green shoots' expected only toward the end of the year.

Management expects the ALP retail rollout to mirror the early trajectory of FRE, focusing on stores where the company already has established distribution.

The goal is to 'round up' the portfolio within existing retail footprints while pursuing new large-scale chain wins.

Management is focused on winning with current flavor profiles and moisture levels rather than immediate new product launches.

They expressed confidence that their existing portfolio covers the largest segments of the market, though they may invest in new flavors as store counts mature.

Management noted that tobacco companies have managed tax fluctuations for decades and that state-level hikes create a level playing field for all manufacturers.

They do not expect tax increases to disadvantage their specific brands relative to competitors.

One stock. Nvidia-level potential. 30M+ investors trust Moby to find it first. Get the pick. Tap here.